Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  66,467 results for ""Zoledronic Acid""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Evaluate the renal system damage caused by zoledronic acid: a comprehensive analysis of adverse events from FAERS.

  • Authors : Wang Z; Department of Thoracic Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.; Su X

Subjects: Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/adverse effects ; Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/therapeutic use ; Adverse Drug Reaction Reporting Systems*

  • Source: BMC cancer [BMC Cancer] 2024 Dec 18; Vol. 24 (1), pp. 1520. Date of Electronic Publication: 2024 Dec 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Efficacy of a single 5 mg zoledronic acid infusion in preventing bone loss and fracture in postmenopausal women with breast cancer.

  • Authors : Baek HS; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.; Shin K

Subjects: Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/administration & dosage ; Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/therapeutic use ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

  • Source: Journal of bone and mineral metabolism [J Bone Miner Metab] 2024 Nov; Vol. 42 (6), pp. 720-727. Date of Electronic Publication: 2024 Sep 30.Publisher: Japanese Society of Bone and Mineral Metabolism Country of Publication: Japan NLM ID: 9436705 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Novel combined pharmacological strategy to alleviate acute phase response following zoledronic acid treatment.

  • Authors : Chen CH; Orthopaedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.; Division of Adult Reconstruction Surgery, Department of Orthopedics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

Subjects: Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/therapeutic use ; Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/administration & dosage ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use

  • Source: Archives of osteoporosis [Arch Osteoporos] 2024 Oct 15; Vol. 19 (1), pp. 97. Date of Electronic Publication: 2024 Oct 15.Publisher: Springer Country of Publication: England NLM ID: 101318988 Publication Model: Electronic Cited Medium: Internet ISSN: 1862-3514

Record details

Read More Add to Saved list
×
Academic Journal

Inpatient zoledronic acid in older hip fracture patients is well tolerated and safe.

Subjects: Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/administration & dosage ; Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/therapeutic use ; Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/adverse effects

  • Source: Archives of osteoporosis [Arch Osteoporos] 2024 Oct 10; Vol. 19 (1), pp. 96. Date of Electronic Publication: 2024 Oct 10.Publisher: Springer Country of Publication: England NLM ID: 101318988 Publication Model: Electronic Cited Medium: Internet ISSN: 1862-3514

Record details

Read More Add to Saved list
×
Academic Journal

Zoledronic Acid Inhibits Lipopolysaccharide-Induced Osteoclastogenesis by Suppressing Macrophage NLRP3-Mediated Autophagy Pathway.

  • Authors : Cheng Y; School/Hospital of Stomatology, Guizhou Medical University, Guiyang, China.; Faculty of Dentistry, Prince of Songkla University, Hat Yai, Thailand.

Subjects: Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/pharmacology ; Autophagy*/Autophagy*/Autophagy*/drug effects ; Lipopolysaccharides*/Lipopolysaccharides*/Lipopolysaccharides*/toxicity

  • Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Dec; Vol. 12 (12), pp. e70094.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Peri-operative zoledronic acid attenuates peri-prosthetic osteolysis in a rat model of cemented knee replacement.

  • Authors : Mann KA; Department of Orthopedic Surgery, Institute for Human Performance, SUNY Upstate Medical University, Syracuse, New York, USA.; Miller MA

Subjects: Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/administration & dosage ; Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/therapeutic use ; Osteolysis*/Osteolysis*/Osteolysis*/prevention & control

  • Source: Journal of orthopaedic research : official publication of the Orthopaedic Research Society [J Orthop Res] 2024 Dec; Vol. 42 (12), pp. 2693-2704. Date of Electronic Publication: Publisher: Wiley Country of Publication: United States NLM ID: 8404726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-527X

Record details

Read More Add to Saved list
×
Academic Journal

Zoledronic Acid Accelerates Bone Healing in Carpal Navicular Fracture via Silencing Long Non-coding RNA Growth Arrest Specificity 5 to Modulate MicroRNA-29a-3p Expression.

  • Authors : Liu X; Department of Orthopaedic Trauma 2, The Third Hospital of ShiJiaZhuang, No. 15 Tiyu South Street, Chang'an District, Shijiazhuang City, 050011, Hebei Province, China. .; Tian L

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics

  • Source: Molecular biotechnology [Mol Biotechnol] 2024 Nov; Vol. 66 (11), pp. 3238-3251. Date of Electronic Publication: 2023 Oct 20.Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Risk of first hip fracture under treatment with zoledronic acid versus alendronate: a NOREPOS cohort study of 88,000 Norwegian men and women in outpatient care.

  • Authors : Riska BSL; Norwegian Research Centre for Women's Health, Oslo University Hospital, Oslo, Norway. .; Department of Physical Health and Ageing, Norwegian Institute of Public Health, Oslo, Norway. .

Subjects: Hip Fractures*/Hip Fractures*/Hip Fractures*/epidemiology ; Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/therapeutic use ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use

  • Source: Archives of osteoporosis [Arch Osteoporos] 2024 Oct 23; Vol. 19 (1), pp. 102. Date of Electronic Publication: 2024 Oct 23.Publisher: Springer Country of Publication: England NLM ID: 101318988 Publication Model: Electronic Cited Medium: Internet ISSN: 1862-3514

Record details

Read More Add to Saved list
×
Academic Journal

Zoledronic acid enhances tumor growth and metastatic spread in a mouse model of jaw osteosarcoma.

  • Authors : Nham TT; Nantes Université, CHU Nantes, Service de Chirurgie Maxillo-Faciale et Stomatologie, Nantes, France.; Nantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Nantes, France.

Subjects: Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/therapeutic use ; Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/pharmacology ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/drug therapy

  • Source: Oral diseases [Oral Dis] 2024 Oct; Vol. 30 (7), pp. 4209-4219. Date of Electronic Publication: 2024 Feb 20.Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9508565 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1601-0825

Record details

Read More Add to Saved list
×
Academic Journal

[Hyperparathyroidism in patients with low bone mineral density treated with zoledronic acid or denosumab].

Subjects: Denosumab*/Denosumab*/Denosumab*/therapeutic use ; Denosumab*/Denosumab*/Denosumab*/adverse effects ; Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/therapeutic use

  • Source: Medicina clinica [Med Clin (Barc)] 2024 Dec 27; Vol. 163 (12), pp. 595-599. Date of Electronic Publication: 2024 Oct 09.Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  66,467 results for ""Zoledronic Acid""